D

Hims & Hers Health, Inc. HIMS

$27.51 $0.070.26% NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

Company Overview

Hims & Hers Health, Inc. is a U.S.-based telehealth and wellness company that operates primarily through a direct-to-consumer digital healthcare platform. The company provides online access to licensed healthcare professionals, prescription and non-prescription treatments, and wellness products across several healthcare categories, including mental health, dermatology, sexual health, primary care, weight management, and hair loss. The company operates within the broader digital health, telemedicine, consumer healthcare, and pharmaceutical fulfillment industries.

The company’s primary revenue drivers include subscription-based healthcare services, recurring prescription fulfillment, and sales of branded wellness products through its online platform. Its customer base consists largely of consumers seeking convenient, digitally enabled healthcare access without traditional in-person visits. A significant strategic differentiator is the integration of telehealth consultations, pharmacy fulfillment, and consumer branding into a single platform. Founded in 2017 by Andrew Dudum and Jack Abraham, the company initially focused on men’s wellness under the “Hims” brand before expanding into women’s healthcare through “Hers.” The company later broadened into chronic care, mental health, and preventative health services, reflecting a wider consumer healthcare strategy.

Business Operations

The company primarily operates through a unified digital healthcare ecosystem that combines telemedicine consultations, prescription management, subscription services, and e-commerce fulfillment. Its core operating activities include online patient intake, clinician consultations conducted through affiliated provider groups, pharmacy coordination, and direct shipment of medications and wellness products. Revenue is largely generated from recurring subscriptions for treatment plans and prescription products. The company also derives revenue from non-prescription wellness and personal care products sold directly to consumers.

Operationally, the company serves customers primarily in the United States, supported by partnerships with licensed healthcare providers and pharmacy infrastructure. Key operational assets include its proprietary digital platform, customer acquisition capabilities, telehealth technology infrastructure, and pharmacy relationships. The company has expanded fulfillment and pharmacy capabilities through acquisitions and partnerships, including relationships with compounding pharmacies and healthcare service providers. Notable subsidiaries and brands include Hims, Hers, and related pharmacy and healthcare service operations integrated into the company’s digital platform.

Strategic Position & Investments

The company’s strategic direction has focused on expanding into broader categories of personalized and preventative healthcare while increasing customer lifetime value through recurring subscription services. Growth initiatives have included the expansion of mental health offerings, weight management services, sexual wellness products, and primary care capabilities. The company has also invested heavily in marketing, technology infrastructure, and customer acquisition to strengthen brand recognition in the competitive telehealth market.

Hims & Hers has pursued acquisitions and strategic investments to enhance pharmacy operations, clinical capabilities, and fulfillment efficiency. The company has shown increased involvement in emerging healthcare areas such as digital chronic care management and GLP-1-related weight management services. Its positioning emphasizes consumer accessibility, transparent pricing, and vertically integrated telehealth delivery. Public filings and investor materials indicate that management continues to prioritize subscription growth, operational scale, and expansion into additional healthcare categories while navigating evolving healthcare regulations and telemedicine reimbursement frameworks.

Geographic Footprint

The company is headquartered in San Francisco, California, and primarily operates across the United States through its digital platform. Because its services are delivered online, the company maintains nationwide consumer reach subject to state-level healthcare and prescribing regulations. Its operational footprint includes distributed healthcare provider networks, pharmacy partnerships, fulfillment operations, and digital customer service infrastructure.

Although the company’s core revenue base remains concentrated in the U.S. market, its platform-based model provides scalability across multiple regions without requiring extensive physical clinic infrastructure. Public disclosures indicate that the company’s strategic focus remains predominantly domestic, with brand awareness and customer penetration efforts centered on major U.S. metropolitan and suburban markets. Data regarding material international operational expansion remains inconclusive based on available public sources.

Leadership & Governance

Leadership at Hims & Hers has emphasized consumer-centric healthcare delivery, digital accessibility, and brand-driven engagement. The company’s governance structure reflects a technology-enabled healthcare strategy that combines healthcare operations, consumer marketing, and subscription commerce expertise. Founder-led management remains central to the company’s strategic direction, particularly around healthcare accessibility and platform expansion.

Key executives include:

  • Andrew Dudum – Chief Executive Officer and Co-Founder
  • Yemi Okupe – Chief Financial Officer
  • Melissa Baird – Chief Operating Officer
  • Nader Kabbani – Chief Product Officer
  • Michael Chi – Chief Corporate Affairs and Legal Officer
  • Joe Spector – President

The company’s leadership has consistently communicated a strategy focused on expanding personalized healthcare access through technology integration, recurring subscription relationships, and broader category diversification within digital health services. Governance and operational disclosures are primarily detailed through SEC filings, including annual reports and investor presentations.

Data compiled by narrative technology. May contain errors.

Top Tech Stocks
See All »
B
NVDA NASDAQ $218.29
B
AAPL NASDAQ $332.27
B
AVGO NASDAQ $361.99
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $107.15
A
Top Financial Stocks
See All »
B
B
JPM NYSE $356.23
B
V NYSE $370.45
Top Health Care Stocks
See All »
B
LLY NYSE $1,115.70
B
JNJ NYSE $265.58
B
ABBV NYSE $257.12
Top Real Estate Stocks
See All »
B
PLD NYSE $135.75
B
EQIX NASDAQ $1,037.72